Previous Close | 12.75 |
Open | 12.43 |
Bid | 0.00 x 0 |
Ask | 0.00 x 0 |
Day's Range | 11.99 - 12.45 |
52 Week Range | 1.19 - 14.90 |
Volume | 243,696 |
Avg. Volume | 450,626 |
Market Cap | 893.78M |
Beta (5Y Monthly) | 1.58 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -1.87 |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
mRNA Vaccine Maker Announced as a First-Round Winner of NGen Strategic Supply ChallengeCALGARY, AB and TORONTO, Jan. 21, 2021 /CNW/ - Providence Therapeutics welcomes today's announcement by Next Generation Manufacturing Canada (NGen) that it has been named as one of eight companies receiving funding to advance its COVID-19 vaccine research and support its manufacturing capacity.
AMOS, QC, Jan. 15, 2021 /CNW Telbec/ -Â Canada Economic Development for Quebec Regions (CED)To support organizations in the tourism sector and prepare them for an eventual recovery, the Government of Canada will announce financial assistance in several regions across Quebec on January 18 and 19, 2021.